Impecin

Imipenem/cilastatin, the active ingredient in Impecin, is a carbapenem antibiotic presented as a sterile powder for reconstitution for intravenous and inhalation use. It treats a range of serious bacterial infections in adult patients, including intra‑abdominal, urinary tract, respiratory and skin infections.

GNH USA supplies Impecin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

Impecin (imipenem/cilastatin) is a carbapenem antibiotic used to treat severe bacterial infections across several organ systems.

Complicated intra‑abdominal infections: achieves clinical cure and microbiological eradication of susceptible pathogens. Complicated urinary tract infections: provides effective bacterial clearance and symptom resolution. Nosocomial pneumonia: facilitates rapid improvement in respiratory function and infection control. Skin and soft tissue infections: promotes healing by eliminating causative bacteria.

Impecin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Vomiting - Rash

Serious or Rare Side Effects: - Seizures, especially in patients with renal impairment or CNS disorders - Anaphylactic or severe allergic reactions - Clostridioides difficile‑associated colitis - Stevens‑Johnson syndrome or toxic epidermal necrolysis

Use Impecin with careful clinical monitoring and appropriate patient assessment. - Renal function assessment: evaluate creatinine clearance before initiating therapy. - Dose adjustment: modify dose in patients with impaired renal function. - Seizure risk: monitor for neurological symptoms, especially in those with CNS disorders. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Concomitant valproic acid: avoid due to increased seizure risk. - Store at below 25°C: keep in original packaging, protect from moisture and light.

Impecin can interact with several medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Valproic acid: increased risk of seizures. - Probenecid: reduced renal clearance of imipenem. - Warfarin: potential increase in INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Diuretics: electrolyte disturbances may enhance neurotoxicity. - Other nephrotoxic agents (e.g., aminoglycosides): heightened risk of renal impairment. - Antacids containing magnesium or aluminum: may affect absorption of concomitant oral agents.